Risk factor
Very high price volatility
Profitability factor
Greatly overvalued vs peers
About
Hinge Health, Inc. develops health care software for joint and muscle health. The company designs its platform to address a musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation. It also provides various administrative and operations support services. The company was founded in 2012 and is headquartered in San Francisco, California.
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, overpriced
Target Price
The average target price of HNGE is 66 and suggests 58% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell